Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol

BACKGROUND: Two-thirds of U.S. adult women are overweight or obese. High body mass index (BMI) and adult weight gain are risk factors for a number of chronic diseases, including postmenopausal breast cancer. The higher postmenopausal breast cancer risk in women with elevated BMI is likely to be attr...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez, Jessica A., Chalasani, Pavani, Thomson, Cynthia A., Roe, Denise, Altbach, Maria, Galons, Jean-Philippe, Stopeck, Alison, Thompson, Patricia A., Villa-Guillen, Diana Evelyn, Chow, H-H. Sherry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950218/
https://www.ncbi.nlm.nih.gov/pubmed/27430256
http://dx.doi.org/10.1186/s12885-016-2551-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950218/
https://www.ncbi.nlm.nih.gov/pubmed/27430256
http://dx.doi.org/10.1186/s12885-016-2551-3

Ejemplares similares